Patent 7683193 was granted and assigned to University of Southern California on March, 2010 by the United States Patent and Trademark Office.
Benzolipoxin analogs, methods of their preparation and pharmaceutical compositions containing the compounds are provided. The compounds and compositions are useful in methods for treatment of various diseases, including, inflammation, autoimmune disease and abnormal cell proliferation.